Clinical Trial

Speech Learning and Speech Production in Parkinson's Disease

Recruiting
View on ClinicalTrials.gov →
Summary
Parkinson's disease, a common movement disorder that results from a breakdown in the brain, often leads to challenges with talking, but less is known about the relationship between difficulties with talking and difficulties with learning to understand speech. By linking these two abilities in individuals with Parkinson's disease using a precision medicine approach, this project seeks to build a basis for new therapies that help people with Parkinson's disease both understand better and speak more clearly.
Trial Details
NCT Number NCT07403539
Lead Sponsor State University of New York at Buffalo
Conditions Parkinson's Disease
Enrollment 50 participants
Start Date 2026-01-27
Primary Completion 2027-12-31 (estimated)
Study Completion 2027-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-02-11